Table of Contents
- What are the Benefits of Magnolia Officinalis (Bark Powder Extract) Supplement?
- What is an appropriate Magnolia Bark Extract Dosage (How much should I take)?
- Can Magnolia bark be used for improving sleep?
- What is a good Magnolia Bark Dosage for Sleep?
- When to take Magnolia bark for sleep?
- Does Magnolia Bark have any Withdrawal Effects?
- Can Magnolia Bark Extract cause the effects of a “High”?
- What is Magnolol and Honokiol?
- Does Magnolia Bark affect Dopamine?
- Can Magnolia Bark activate Cannabinoid receptors in the body?
- Can Magnolia bark be used for relieving anxiety?
- What is Dihydro Honokiol?
- Can Magnolia bark lower Cortisol levels in the body?
- Does Magnolia bark interact with GABA receptors?
- Can Magnolia bark be used for managing depression?
- Magnolia bark vs. Ashwagandha, what is the difference?
- Do Magnolia bark and Ziziphus bark extracts interact with CNS receptors?
- Can Magnolia bark be used to treat OCD?
- Want to know more?
- Sources
What are the Benefits of Magnolia Officinalis (Bark Powder Extract) Supplement?
- Anti Inflammatory
- Relieves Pain
- Antibacterial (reduces oral plaque buildup)
- Antioxidant
- Anti Cancer
- Relieves Stress and Anxiety
- Reduces Depression
- Enhances Memory and Learning
- Reduces Adrenaline
- Improve Sleep
- Improves Symptoms of Menopause
- Helps Weight Management
- Reduces Allergies
In the video below, David Tellman explains the nootropic benefits of Magnolia Bark. Including why we use Magnolia Bark as a nootropic, recommended dosage, side effects, clinical research, and the best type of Magnolia Bark to buy.
This is our recommended Magnolia supplement (Amazon’s Choice):
What is an appropriate Magnolia Bark Extract Dosage (How much should I take)?
Dosages below are for a 1-10% basic Magnolia Bark extract:
- For general health, stress: 200-400mg
- For menopausal symptoms: one 60 mg tablet
- For learning or depression: 1.1-2.2mg/kg (220-440 mg for a 200lb person)
- For anxiety, sedation, and epilepsy: 5-10 mg
- Herbal preparations used as decoctions: 3 to 10 g per person
- Relora: one 300 mg capsule 2 to 3 times daily
The typical dosage for Magnolia Bark extract supplements ranges from 200 to 800 mg daily.
In general, it is recommended that users begin with the lowest suggested dose, and gradually increase as needed. Keep in mind that natural products are not always necessarily safe. Be sure to follow the directions on product labels and consult your doctor before using them.
Can Magnolia bark be used for improving sleep?
Magnolia bark can be used for improving sleep. It has been used to remedy insomnia for centuries. The active components of magnolia bark are polyphenols honokiol and magnolol, which have been discovered to help induce sleep.
One animal study observed that a magnolol dose of 2.3–0.9 mg per pound (5–25 mg per kg) of body weight greatly reduced sleep latency or the amount of time it takes to fall asleep. The study also found that the administration of magnolia increased REM (rapid eye movement) and non-REM sleep.
Another animal study observed identical results after administering honokiol, reducing the time it took the mice to fall asleep and shift into non-REM sleep.
What is a good Magnolia Bark Dosage for Sleep?
Typical Magnolia Bark supplement doses for sleep are 200-400mg, and up to 500 mg per day. Individual dosing will vary, depending on body weight, health conditions, and the strength of the extract.
When to take Magnolia bark for sleep?
Magnolia bark should be taken at night before bed as a sleeping aid. Recommended starting dosage is around 200-250 mg. You can gradually increase it as you become accustomed to magnolia bark’s effects. However, it is advised not to exceed 400 mg of the extract.
Always contact a dietician before adding a supplement to your diet.
Does Magnolia Bark have any Withdrawal Effects?
Magnolia Bark causes a stress-relieving effect through sedation, so its withdrawal effects are likened to benzodiazepines:
- mouth/throat numbness
- lightheadedness
- tiredness
- dizziness
However, some Magnolia Bark users don’t experience any withdrawal effects.
Magnolia Bark is less likely to cause “motor dysfunction” than benzodiazepines, so sometimes it’s used to taper off and lighten the withdrawal effects of benzodiazepines.
Can Magnolia Bark Extract cause the effects of a “High”?
Magnolia Bark Extract can reduce stress due to “honokiol”, which works similarly to prescription sedatives. Both Magnolia and prescription sedatives increase the levels of GABA, a relaxing hormone. The difference is that honokiol works in specific areas of the brain, and prescription sedatives affect receptors throughout the entire body, causing the effects of a “high” like hangover, muscle weakness, fatigue, and more. Magnolia, being more selective, should not make you feel “high” or doped up.
What is Magnolol and Honokiol?
Magnolol and Honokiol are plant compounds with antioxidant properties isolated from Magnolia. These bioactive constituents have various therapeutic activities and can be potentially useful for the treatment of various conditions such as inflammation, pain, CVS injury, cancer, and cognitive disorders.
The following are some beneficial properties of Magnolol and Honokiol:
- Antioxidant property: Animal and in-vitro studies show that magnolol and honokiol decrease free radicals generated by UV radiation leading to a reduction in oxidative stress. The antioxidant activity of these two is more potent than 𝛂-tocopherol and can protect heart mitochondria from free radical damage.
- Anti-inflammatory activity: Studies show magnolol and honokiol can cross the blood-brain barrier and reduce inflammation in the brain by inhibiting the release of inflammatory agents resulting in a decrease in pain.
- Anti-tumor activity: Animal studies show that these plant compounds can inhibit cancer tumor growth.
- Antimicrobial property: In-vitro studies show that magnolol and honokiol exhibit inhibitory activity against gram-positive and gram-negative bacteria as well as fungi.
Does Magnolia Bark affect Dopamine?
Magnolia bark acts as an antidepressant by affecting the activity of dopamine, a neurotransmitter important to mood.
Magnolia Bark extract (containing magnolol and honokiol) inhibits the dopamine transporter activity and reduces binding to dopamine D5 receptors. This means Magnolia Bark is forcing the transporter and receptor to release dopamine for reuse in your brain. So it doesn’t deplete dopamine but rather helps the brain to use it more efficiently.
Can Magnolia Bark activate Cannabinoid receptors in the body?
Magnolia bark can activate cannabinoid (CB) receptors. Research found that its main bioactive constituents, magnolol, and honokiol, can act as partial and full activators to CB1 and CB2 receptors, respectively.
Due to this, magnolia bark is commonly used in Asian traditional medicine for the treatment of anxiety, sleeping disorders, and allergic diseases.
Cannabinoid receptors are a class of receptors involved in various physiological and pathophysiological functions in the body, including regulating mood, pain sensation, vascular appetite, nonvascular smooth muscle tone, and immune function.
Can Magnolia bark be used for relieving anxiety?
Magnolia bark can be used for relieving anxiety. It is observed that magnolia bark extract seems to have protective effects against many neurological ailments. This includes brain disorders like Alzheimer’s disease and conditions like anxiety, mood disorders, and depression.
A study on 40 women in the age group 20–50 found that administering 250 mg of Magnolia bark extract 3 times a day significantly alleviated short-term and temporary anxiety more than a placebo.
Nonetheless, the supplement used in this study included compounds other than magnolia bark. Thus, the result of this study cannot be credited to the tree bark alone.
What is Dihydro Honokiol?
Dihydro Honokiol is a partially reduced derivative of honokiol. Research has confirmed that it is a potent anxiolytic-like agent that interacts with the benzodiazepine site GABA(A) receptor to promote non-rapid eye movement (NREM) sleep.
Can Magnolia bark lower Cortisol levels in the body?
Magnolia bark can be used to lower cortisol levels in the body. A study on 56 adults revealed that consuming 500 mg of Magnolia bark extract daily resulted in significantly lower cortisol levels and improved mood.
Cortisol is the primary stress hormone in your body. High quantities of cortisol in the body have been linked to high anxiety and stress levels.
Does Magnolia bark interact with GABA receptors?
Magnolia bark can activate GABA pathways. A 2013 review showed that the active compound honokiol in Magnolia Bark interacts with the central nervous system’s GABA(A) receptor. GABA(A) receptor regulates mood and induces sleep; this is the same receptor targeted by anti-anxiety medication like diazepam.
Research shows that Magnolia bark can improve sleep by interacting with this receptor. This research looked at how honokiol facilitated NREM sleep by modulating the benzodiazepine site of the GABA(A) receptor, indicating possible use in the treatment of insomnia, particularly for individuals who undergo difficulty falling and staying asleep.
Another study showed that magnolol and honokiol enhanced hippocampus neurons’ pre-synaptic and post-synaptic GABA transmission.
Can Magnolia bark be used for managing depression?
Magnolia bark can be used to manage depression. Research shows that magnolia bark extract is an effective agent for managing depression and other neurological conditions, including stress, mood disorders, anxiety, and brain disorders such as Alzheimer’s disease.
Furthermore, animal studies have also shown magnolia bark extract to cause antidepressant-like effects, such as increased serotonin levels in the brain and reduced corticosterone levels in the blood. Corticosterone and serotonin each have a major role in regulating depression, mood, and anxiety.
Magnolia bark vs. Ashwagandha, what is the difference?
Magnolia bark and Ashwagandha are herbal supplements used to manage stress and anxiety.
These supplements are different in origin and working. Many products use a combination of magnolia bark and ashwagandha to make a complete stress defense supplement.
Ashwagandha is of Indian origin, and studies have shown it to display impressive anti-anxiety and anti-stress effects via regulation of the hypothalamic-pituitary-adrenal and sympathetic-adrenal-medullary axis.
While magnolia bark is of Chinese origin, and studies have shown it to promote healthy sleeping by interacting with GABA(A) and Cannabinoid receptors in the central nervous system to reduce stress and anxiety.
Do Magnolia bark and Ziziphus bark extracts interact with CNS receptors?
Magnolia bark and Ziziphus extracts interact with CNS (central nervous system) receptors. Research shows them to interact with the following:
- Adenosine A1 receptor
- Dopamine transporter
- Dopamine D5 receptor (antagonist activity)
- Serotonin receptors (5-HT1B and 5-HT6 antagonist activity)
- GABA benzodiazepine receptor
Interactions with these selected receptors in the CNS are the primary reason for the sleep-inducing effects of these extracts.
Can Magnolia bark be used to treat OCD?
Magnolia bark may be used to treat OCD, a disorder that involves invasive thoughts that cause anxiety or stress. Multiple studies have shown magnolia bark to reduce stress and anxiety in individuals.
Furthermore, research has also observed magnolia bark to work like an anxiolytic. Anxiolytic is a medication or additional intervention that lowers anxiety. Anxiolytics are also used to treat people with OCD and OCRD.
Want to know more?
Click the links below to access the individual topic pages:
Sources
This article makes use of information from the U.S. National Library of Medicine under the terms of the Creative Commons Attribution 4.0 International License.
- Yi LT, Xu Q, Li YC, Yang L, Kong LD. Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):616-24. doi: 10.1016/j.pnpbp.2009.03.001. Epub 2009 Mar 11. PMID: 19285110.
- Mucci M, Carraro C, Mancino P, Monti M, Papadia LS, Volpini G, Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol. 2006 Aug;58(4):323-34. PMID: 16957676.
- Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J. 2008;7:11. Published 2008 Apr 21. doi:10.1186/1475-2891-7-11
- Garrison R, Chambliss WG. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern Ther Health Med. 2006 Jan-Feb;12(1):50-4. PMID: 16454147.
- Hellström MK, Ramberg P. The effect of a dentifrice containing Magnolia extract on established plaque and gingivitis in man: a six-month clinical study. Int J Dent Hyg. 2014 May;12(2):96-102. doi: 10.1111/idh.12047. Epub 2013 Aug 23. PMID: 24034670.
- Chen CR, Zhou XZ, Luo YJ, Huang ZL, Urade Y, Qu WM. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABA(A) receptor in mice. Neuropharmacology. 2012 Nov;63(6):1191-9. doi: 10.1016/j.neuropharm.2012.06.031. Epub 2012 Jul 4. PMID: 22771461.
- Rajgopal A, Missler SR, Scholten JD. Magnolia officinalis (Hou Po) bark extract stimulates the Nrf2-pathway in hepatocytes and protects against oxidative stress. J Ethnopharmacol. 2016 Dec 4;193:657-662. doi: 10.1016/j.jep.2016.10.016. Epub 2016 Oct 6. PMID: 27721050.
- Talarek S, Listos J, Barreca D, Tellone E, Sureda A, Nabavi SF, Braidy N, Nabavi SM. Neuroprotective effects of honokiol: from chemistry to medicine. Biofactors. 2017 Nov;43(6):760-769. doi: 10.1002/biof.1385. Epub 2017 Aug 17. PMID: 28817221.
- Tachikawa E, Takahashi M, Kashimoto T. Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem Pharmacol. 2000 Aug 1;60(3):433-40. doi: 10.1016/s0006-2952(00)00343-9. PMID: 10856439.
- Rempel V, Fuchs A, Hinz S, et al. Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. ACS Med Chem Lett. 2012;4(1):41-45. Published 2012 Nov 14. doi:10.1021/ml300235q
- Lee YJ, Choi DY, Han SB, et al. A Comparison between Extract Products of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer’s Disease. Biomol Ther (Seoul). 2012;20(3):332-339. doi:10.4062/biomolther.2012.20.3.332
- Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. PMID: 31002949.
- Shin TY, Kim DK, Chae BS, Lee EJ. Antiallergic action of Magnolia officinalis on immediate hypersensitivity reaction. Arch Pharm Res. 2001 Jun;24(3):249-55. doi: 10.1007/BF02978266. PMID: 11440086.
- Shen JL, Man KM, Huang PH, Chen WC, Chen DC, Cheng YW, Liu PL, Chou MC, Chen YH. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules. 2010 Sep 16;15(9):6452-65. doi: 10.3390/molecules15096452. PMID: 20877235; PMCID: PMC6257695.
- Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B. 2017;18(3):194-214. doi:10.1631/jzus.B1600299
- Koetter U, Barrett M, Lacher S, Abdelrahman A, Dolnick D. Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors. J Ethnopharmacol. 2009 Jul 30;124(3):421-5. doi: 10.1016/j.jep.2009.05.040. Epub 2009 Jun 6. PMID: 19505549.
- Chen CR, Zhou XZ, Luo YJ, Huang ZL, Urade Y, Qu WM. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABA(A) receptor in mice. Neuropharmacology. 2012 Nov;63(6):1191-9. doi: 10.1016/j.neuropharm.2012.06.031. Epub 2012 Jul 4. PMID: 22771461.
- Qu WM, Yue XF, Sun Y, Fan K, Chen CR, Hou YP, Urade Y, Huang ZL. Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice. Br J Pharmacol. 2012 Oct;167(3):587-98. doi: 10.1111/j.1476-5381.2012.02010.x. PMID: 22537192; PMCID: PMC3449263.
- Woodbury A, Yu SP, Wei L, García P. Neuro-modulating effects of honokiol: a review. Front Neurol. 2013 Sep 11;4:130. doi: 10.3389/fneur.2013.00130. PMID: 24062717; PMCID: PMC3769637.
- Maruyama Y, Kuribara H, Kishi E, Weintraub ST, Ito Y. Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments. J Pharm Pharmacol. 2001 May;53(5):721-5. doi: 10.1211/0022357011775848. PMID: 11370711.
- Talbott SM, Talbott JA, Pugh M. Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013 Aug 7;10(1):37. doi: 10.1186/1550-2783-10-37. PMID: 23924268; PMCID: PMC3750820.
- Fiksdal A, Hanlin L, Kuras Y, Gianferante D, Chen X, Thoma MV, Rohleder N. Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress. Psychoneuroendocrinology. 2019 Apr;102:44-52. doi: 10.1016/j.psyneuen.2018.11.035. Epub 2018 Nov 24. PMID: 30513499; PMCID: PMC6420396.
- Chen CR, Tan R, Qu WM, Wu Z, Wang Y, Urade Y, Huang ZL. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice. Br J Pharmacol. 2011 Nov;164(5):1534-46. doi: 10.1111/j.1476-5381.2011.01456.x. PMID: 21518336; PMCID: PMC3221106.
- Alexeev M, Grosenbaugh DK, Mott DD, Fisher JL. The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology. 2012 Jun;62(8):2507-14. doi: 10.1016/j.neuropharm.2012.03.002. Epub 2012 Mar 12. PMID: 22445602; PMCID: PMC3652012.
- Xu Q, Yi LT, Pan Y, Wang X, Li YC, Li JM, Wang CP, Kong LD. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):715-25. doi: 10.1016/j.pnpbp.2007.11.020. Epub 2007 Nov 28. PMID: 18093712.
- Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia. Curr Neuropharmacol. 2021;19(9):1468-1495. doi: 10.2174/1570159X19666210712151556. PMID: 34254920; PMCID: PMC8762185.
- Borgonetti V, Governa P, Manetti F, Miraldi E, Biagi M, Galeotti N. A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor. J Pharm Pharmacol. 2021 Aug 12;73(9):1161-1168. doi: 10.1093/jpp/rgab067. PMID: 33950239.
- Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017. PMID: 30101713; PMCID: PMC7059159.
- Lo YC, Teng CM, Chen CF, Chen CC, Hong CY. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol. 1994 Feb 9;47(3):549-53. doi: 10.1016/0006-2952(94)90187-2. PMID: 8117323.
- Kaushik DK, Mukhopadhyay R, Kumawat KL, Gupta M, Basu A. Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation. J Neuroinflammation. 2012 Mar 19;9:57. doi: 10.1186/1742-2094-9-57. PMID: 22429472; PMCID: PMC3325890.
- Clark AM, El-Feraly FS, Li WS. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci. 1981 Aug;70(8):951-2. doi: 10.1002/jps.2600700833. PMID: 7310672.
- Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, Bae KH. Antifungal activity of magnolol and honokiol. Arch Pharm Res. 2000 Feb;23(1):46-9. doi: 10.1007/BF02976465. PMID: 10728656.
- Konoshima T, Kozuka M, Tokuda H, Nishino H, Iwashima A, Haruna M, Ito K, Tanabe M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J Nat Prod. 1991 May-Jun;54(3):816-22. doi: 10.1021/np50075a010. PMID: 1659613.
- Fujita S, Taira J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med. 1994 Sep;17(3):273-7. doi: 10.1016/0891-5849(94)90083-3. PMID: 7982632.